John Rhodes to Treatment Outcome
This is a "connection" page, showing publications John Rhodes has written about Treatment Outcome.
Connection Strength
0.695
-
Expanding Transcatheter Pulmonary Valve Therapies. JACC Cardiovasc Interv. 2020 12 14; 13(23):2766-2768.
Score: 0.079
-
Tipping Point: When Does Unilateral Branch Pulmonary Artery Stenosis Impede Exertional Performance? JACC Cardiovasc Interv. 2019 02 11; 12(3):298-300.
Score: 0.070
-
Combined prospective United States clinical study data for the GORE(?) HELEX(?) septal occluder device. Catheter Cardiovasc Interv. 2014 May 01; 83(6):944-52.
Score: 0.049
-
Recurrent cerebral abscess secondary to a persistent left superior vena cava. Congenit Heart Dis. 2014 May-Jun; 9(3):E78-84.
Score: 0.047
-
A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk. Catheter Cardiovasc Interv. 2013 Mar; 81(4):654-9.
Score: 0.045
-
Percutaneous interventions in high-risk patients following Mustard repair of transposition of the great arteries. Catheter Cardiovasc Interv. 2012 Nov 15; 80(6):905-14.
Score: 0.043
-
Complete resolution of systemic venous baffle obstruction and baffle leak using the Gore Excluder covered stent in two patients with transposition of the great arteries and prior Mustard procedure. Catheter Cardiovasc Interv. 2010 Nov 15; 76(6):878-81.
Score: 0.039
-
Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis. Am J Cardiol. 2006 Aug 01; 98(3):407-10.
Score: 0.029
-
Transcatheter interventions across an inferior vena cava filter. Catheter Cardiovasc Interv. 2003 Jul; 59(3):333-7.
Score: 0.024
-
Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial. Circ Cardiovasc Interv. 2022 01; 15(1):e010852.
Score: 0.021
-
Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study. Catheter Cardiovasc Interv. 2022 04; 99(5):1551-1557.
Score: 0.021
-
Hemodynamic Impact of MitraClip Procedure for Systemic Tricuspid Regurgitation in Congenitally Corrected Transposition of Great Arteries: A Case Report. Cardiovasc Revasc Med. 2021 07; 28S:114-117.
Score: 0.019
-
SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter Cardiovasc Interv. 2019 04 01; 93(5):859-874.
Score: 0.018
-
3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for?Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018 10 08; 11(19):1920-1929.
Score: 0.017
-
Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study. Int J Stroke. 2017 12; 12(9):998-1004.
Score: 0.015
-
Maladaptive aortic properties after the Norwood procedure: An angiographic analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial. J Thorac Cardiovasc Surg. 2016 08; 152(2):471-479.e3.
Score: 0.014
-
Changes in speckle tracking echocardiography measures of ventricular function after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position. Echocardiography. 2015 Mar; 32(3):461-9.
Score: 0.013
-
Device closure of secundum atrial septal defects in infants weighing less than 8 kg. Pediatr Cardiol. 2014 Oct; 35(7):1124-31.
Score: 0.012
-
Impact of pre-stage II hemodynamics and pulmonary artery anatomy on 12-month outcomes in the Pediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1467-74.
Score: 0.012
-
Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. Circulation. 2013 Aug 27; 128(9):954-61.
Score: 0.012
-
Early echocardiographic changes after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position. Echocardiography. 2013 Aug; 30(7):786-93.
Score: 0.012
-
Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012 Dec; 5(6):862-70.
Score: 0.011
-
Variation in perioperative care across centers for infants undergoing the Norwood procedure. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):915-21.
Score: 0.011
-
Randomized trial of cutting balloon compared with high-pressure angioplasty for the treatment of resistant pulmonary artery stenosis. Circulation. 2011 Nov 29; 124(22):2388-96.
Score: 0.011
-
Pediatric catheterization laboratory anticoagulation with bivalirudin. Catheter Cardiovasc Interv. 2011 Apr 01; 77(5):671-9.
Score: 0.010
-
Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder. Am J Cardiol. 2008 May 15; 101(10):1487-92.
Score: 0.008
-
Intermediate follow-up following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Interv. 2007 Oct 01; 70(4):569-77.
Score: 0.008
-
Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):276-85.
Score: 0.008
-
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation. 2007 Jul 17; 116(3):293-7.
Score: 0.008
-
Development of the MAGIC congenital heart disease catheterization database for interventional outcome studies. J Interv Cardiol. 2006 Apr; 19(2):173-7.
Score: 0.007